OBALON THERAPEUTICS LEAD PLAINTIFF ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Obalon Therapeutics, Inc. To Contact The Firm

March 16, 2018

Responsive image

NEW YORK, March 16, 2018 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN) of the April 16, 2018 deadline to seek the role of lead plaintiff in a federal securities…

Category: Precious Metals